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Abstract
Problem
Postpartum depression (PPD) can lead to increased risk of child abuse, delays in
infant development, and increased medical costs (Earls et al., 2019). The American
Academy of Pediatrics (AAP) recommends all mothers of infants 0-6 months be screened
for PPD during well-child visits. Despite these recommendations, many pediatric offices
have no PPD screening process.
Methods
This quality improvement project utilized a standardized tool to screen mothers of
infants 0-6 months for PPD during their infants’ well-child visits. Mothers who screened
positive for PPD were offered referrals to treatment resources and given the opportunity
to participate in two follow-up telephone interviews about their experiences.
Results
During the 12-week implementation period, 83.5% of eligible mothers (152/182)
were screened for PPD. Fourteen mothers (9.2%) screened positive for PPD, and six of
those individuals were interviewed by telephone. Of mothers interviewed, two felt they
did not have PPD and did not seek treatment, three had been previously diagnosed with
depression and were receiving services, and one planned to connect with treatment
resources but had not done so five weeks after her initial screening. This mother
identified barriers to treatment, including lack of time, transportation, and childcare.
Implications for Practice
Screening and referring mothers of infants for PPD is feasible in pediatric primary
care and gives objective data that providers can use for follow-up counseling.
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Postpartum depression (PPD) is a subset of perinatal depression, the most
common complication related to childbirth in the United States. Symptoms of PPD are
reported by 11% to 18% of women after childbirth (Earls et al., 2019). According to the
American Academy of Pediatrics (AAP), PPD can lead to delayed infant development,
increased risk of infant abuse and neglect, increased medical costs, breastfeeding
discontinuation, and family dysfunction (Earls et al., 2019). Early recognition and
treatment of PPD is essential to reduce the widespread impact of this mental health
disorder. Screening for PPD with an evidence-based tool, such as the Edinburgh Postnatal
Depression Scale (EPDS), is recommended by the American College of Obstetricians and
Gynecologists (ACOG, 2015), Centers for Medicare and Medicaid Services (CMS,
2016), and the American Academy of Pediatrics (Earls et al., 2019).
The pediatric primary care clinician (PCC) is in an ideal situation to screen for
PPD and connect at-risk mothers with services. Mothers are more likely to keep
appointments for their child’s medical care than their own (Emerson, Mathews, &
Struwe, 2018). The AAP recommends pediatric PCCs incorporate routine screening for
PPD during well-child visits at 1, 2, 4, and 6 months (Earls et al., 2019). By screening all
mothers during well-child visits, those at risk for PPD can be identified early.
Identification has no value, however, without an effective treatment referral process
(Bauer, Ofner, Pottenger, Carrol, & Downs, 2017). It is essential for pediatric providers
to know how to help mothers at risk for PPD access appropriate mental health services
(Earls et al., 2019). By referring mothers who screen positive for PPD for treatment,
mothers can be treated early, minimizing negative effects of this mental health disorder.
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The AAP has recommended screening mothers for PPD in pediatric primary care
since 2010 (Earls et al., 2010). An AAP study conducted in 2019 showed less than half of
pediatric offices follow these recommendations (Earls et al., 2019). The purpose of this
quality improvement initiative was to address this gap by implementing and evaluating a
PPD screening and referral process in a pediatric primary care clinic, with an aim of
screening at least 25% of eligible mothers. The following outcomes were measured: (1)
rate of mothers screened for PPD, (2) rate of mothers identified to be at risk for PPD, (3)
rate of mothers who self-report a follow-up to begin treatment for PPD, and (4) reported
barriers to PPD treatment. This project attempted to answer the following questions: (1)
How does screening mothers of infants 0-6 months old for PPD using the EPDS affect
the identification of mothers at risk for PPD? (2) How does the identification of mothers
at risk for PPD using the EPDS during well-child visits and the referral of these mothers
to treatment resources affect the likelihood of these mothers to begin treatment for PPD?
Review of the Literature
In order to understand the scope of the problem, a comprehensive review of
literature was performed using the Cochrane Library, Medline, and CINAHL. Key words
“postpartum depression screening” were utilized in the Cochrane Library search. This
search yielded four results, all irrelevant to this literature review. Keywords “postpartum
depression screening” AND “pediatric OR child OR children OR infant” were utilized in
Medline and CINAHL searches. Results (n = 288) were filtered to include only articles
published in English between years 2014 and 2019. A total of 97 potential articles were
identified. After removing duplicate articles, 49 abstracts were reviewed. Of these
articles, 14 are included in this review. The remaining 35 articles were not relevant.
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The AAP (Earls et al., 2019) published guidelines for postpartum depression
screening and management in pediatric primary care in January 2019. This policy
statement provides the foundation for this quality improvement project, as it recommends
screening for PPD at 1-, 2-, 4-, and 6-month well-child visits. A descriptive, crosssectional survey of pediatric primary care providers in Oregon found that only 29% of
respondents followed AAP recommendations for PPD screening (Docherty, Najjar,
Combs, Woolley, & Stoyles, 2019).
The literature supports use of a validated PPD screening tool such as the
Edinburgh Postnatal Depression Scale (EPDS). A systematic review published in 2017
concluded screening for PPD using a validated tool during well-child visits led to
significantly higher detection of mothers with depression (Zee-van den Berg, BoereBoonekamp, IJzerman, Haasnoot-Smallegange, & Reijneveld, 2017). A randomized
controlled trial evaluated the accuracy of the EPDS for identifying PPD among mothers,
finding the EPDS is a highly accurate and effective screening tool for PPD (Venkatesh,
Zlotnick, Triche, Ware, & Phipps, 2014).
Three publications reviewed were quality improvement projects with the goal of
meeting AAP screening recommendations for PPD. Magonja and Schoening (2017)
implemented a PPD screening using the EPDS at well-child appointments. Emerson,
Matthews, and Struwe (2018) conducted a similar project but included an assessment of
the practicality of complying with screening recommendations through a staff survey.
This project concluded screening at AAP recommended intervals is feasible.
Russomagno and Waldrop (2019) implemented a similar PPD screening and referral
process, resulting in 47% increase in screening rate and 13% increase in referral rate.
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Two studies attempted to determine if a relationship exists between demographic
factors and PPD screening. One study found the majority of mothers who screened
positive for PPD were African American, single, and did not have a college degree
(Kallem, Matone, Boyd, & Guevara, 2019). A quality improvement project reported lowincome mothers of Hispanic, male infants were more likely to screen positive for PPD
(Sorg, Coddington, Ahmed, & Richards, 2019). As both of these studies had statistically
insignificant findings, this is an area in need of further investigation.
An area of interest is mothers’ treatment seeking behaviors. Bauer et al. (2017)
interviewed mothers who screened positive for PPD about their treatment seeking
behaviors. Less than half of study participants (36/73) reported seeking treatment.
Reported reasons for not seeking treatment included lack of time, lack of transportation,
frustration with the referral process, and perception that symptoms would improve
without treatment. Reported demographic characteristics, including race, ethnicity,
maternal age, marital status, education level, and number of children, were not predictive
of treatment seeking behavior. Canty, Sauter, Zuckerman, Cobian, and Grigsby (2019)
interviewed 17 mothers who screened positive for PPD. Four categories of factors –
attitudes about personal health, family and friends, community, and the health care
system – were identified as barriers or facilitators to treatment seeking behaviors. Kallem
et al. (2018) found that of 263 mothers who screened positive for PPD, only 23 women
(11.8%) received depression treatment. Puryear, Nong, Correa, Cox, and Greeley (2019)
reported only 20% of mothers who screened positive for PPD completed follow-up
appointments. Young et al. (2019) conducted interviews with 20 mothers receiving
mental health care services embedded in a pediatric clinic. This qualitative study
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recognized mothers face many barriers to mental health care and found offering maternal
mental health services in pediatric offices facilitated treatment and improved outcomes.
Weaknesses related to study design limit available literature about PPD screening
in pediatric primary care. Of note, there have only been three quality improvement
projects published in recent years aimed at improving rates of screening. These projects
confirmed screening for PPD using a validated tool is effective at identifying mothers at
risk for PPD (Mgonia & Schoening, 2017; Russomagno & Waldrop, 2019; Sorg,
Coddington, Ahmed, & Richards, 2019). Unfortunately, the majority of relevant literature
available is low level evidence. More rigorous research in this area has not been
implemented, therefore clinicians must rely on non-experimental studies and evidence
from quality improvement projects for best practices. Furthermore, qualitative studies are
limited by small sample sizes, homogeneous samples, and bounded by location.
Gaps in available literature are found in relation to demographic characteristics of
mothers who screen positive for PPD and in referrals for treatment. Research attempting
to define demographic factors that increase a mother’s risk for PPD was not statistically
significant (Kallem et al., 2019; Sorg et al., 2019). Research has been unable to
definitively determine the cause of the disparity between mothers who screen positive for
PPD and those who receive treatment (Bauer et al., 2017; Canty et al., 2019; Kallem et
al., 2019; Young et al., 2019). Other areas needing further investigation include
identifying barriers to PPD treatment and the efficacy of referring mothers to free
community resources, online resources, and other non-traditional mental health services.
The Plan-Do-Study-Act (PDSA) framework was used to implement this quality
improvement initiative. This framework is endorsed by the Institute for Healthcare
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Improvement (IHI, 2019). In the first phase of the framework, project methods, aims, and
outcome measures were established. Second, the intervention was implemented over a
12-week timeframe. Third, the data were analyzed to determine desired outcomes were
achieved. During this phase, successes, failures, and unintended results were identified
and evaluated. In the final phase of the PDSA cycle, the intervention was modified based
on results before the next PDSA cycle (CMS, 2017).
Methods
Design
The quality improvement project was a mixed methods descriptive study utilizing
prospective data collection. The intervention used current evidence-based practice
recommendations from the AAP for screening mothers of infants for PPD and referring
them for treatment (Earls et al., 2019).
Setting
The project was implemented in a private, faith-based pediatric primary care
clinic with two pediatricians and one pediatric nurse practitioner. Clinic visits average
45-60 patients per day, and an estimated 75% of patients receive Medicaid benefits. The
clinic is located in a large Midwestern metropolitan area with a population of 2.85
million (World Population Review, 2019). Prior to implementation of this quality
improvement project, the clinic had no process in place for screening mothers for PPD.
Sample
A convenience sample of postpartum mothers of infants age 1-6 months were
recruited to participate during their infants’ well-child exams. Mothers who did not speak
English or were unable to provide informed consent were included in the screening and
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referral process but were not given the option to receive a follow-up telephone call. One
hundred and fifty-two mothers were screened for PPD using the EPDS, and six mothers
were contacted for follow-up conversations during the 12-week implementation period.
Procedures
During the 12-week implementation period (January 13, 2020 – April 3, 2020), all
mothers of infants age 1-6 months were given the opportunity to participate in PPD
screening during well-child visits using the EPDS. Mothers completed the EPDS
screening on paper while waiting to see providers. Medical assistants scored the EPDS
and notified the respective provider of the individual mother’s scores, highlighting any
positive screens. Scores on the EPDS range from 0-30, with a score greater than 9
considered at risk for PPD. Mothers who scored greater than 9 or identified any thoughts
about self-harm were considered to have positive PPD screens. Providers addressed
results of the PPD screening during well-child visits, offering to make referrals to mental
health providers for mothers with positive screens and encouraging them to utilize the
community resources identified in a handout provided at time of appointment check in.
Mothers who screened positive for PPD were asked to consent to be contacted by
telephone for quality improvement purposes. After the visit, providers documented the
results of the EPDS screening in the child’s medical record and billed for this screening
service using CPT code 96161. Mothers who screened positive for PPD and gave consent
were contacted by telephone 1-2 weeks and 3-5 weeks after initial positive screening.
Data Collection/Analysis
Data were collected every two weeks, including staff screening compliance,
number of mothers who screened positive, and follow-up phone call information.
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Descriptive statistics were used to analyze quantitative data. During follow-up phone
calls, demographic data were collected, along with qualitative data about barriers mothers
experienced connecting with treatment resources and their opinions about the PPD
screening and referral process. Due to small sample size (n=6) and non-normal
distribution of the sample, quantitative statistical analysis was not completed.
Approval Process
The Institutional Review Board (IRB) of the healthcare organization that oversees
the clinic and the University’s IRB approved this quality improvement project prior to
initiation of procedures. Written consent to be contacted and full telephone informed
consent were obtained from all mothers who agreed to participate. Project data were
securely stored, complying with IRB requirements.
Results
During the 12-week implementation period (January 13, 2020 – April 3, 2020),
182 mothers were eligible to be screened for postpartum depression (PPD) using the
Edinburgh Postnatal Depression Scale (EPDS) (Zee-van den Berg et al., 2017). Three
mothers (1.6%) declined screening, and 27 (14.8%) were inadvertently not screened by
staff, resulting in a total of 152 (83.5%) mothers screened for PPD over 12 weeks. Prior
to implementation of this screening process, no mothers were screened for PPD by the
pediatric clinic, yielding a PPD screening rate of zero. After implementation of this
project, screening rates for PPD rose to 83.5% (152/182), rounded to 84% for purposes of
communicating results to stakeholders.
Results are reported on the 152 mothers who were screened for PPD. Distribution
of EPDS scores can be seen in Figure 1. Scores on the EPDS ranged from 0-21 (potential
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score range on the EPDS is 0-30), with a mean of 4.16 and standard deviation of 3.97. A
score less than 10 on the EPDS is considered a negative PPD screen, while a score of 10
or greater is considered a positive PPD screen. Fourteen mothers (9.2%) screened
positive for PPD. Positive scores ranged from 10 (low risk for PPD) to 21 (high risk for
PPD). Of the 14 positive screenings, eight individuals consented to be contacted for a
follow-up interview. One mother screened positive twice during the data collection
period and consented to be contacted both times. Six of the eight mothers who screened
positive for PPD and consented to be contacted were interviewed by telephone. Three of
these mothers were interviewed twice (1-2 and 3-5 weeks after initial positive screening),
three were interviewed once (1-2 weeks after initial positive screening), and two were
unable to be reached by telephone. All five mothers who did not consent to be contacted
scored 10 or 11 on the EPDS (low risk for PPD). Additional attempts to contact mothers
who screened positive for PPD were unable to be made during the last three weeks of
data collection due to hospital IRB-mandated cessation of the project as a result of
unforeseen, non-project related circumstances.
The six mothers interviewed provided qualitative data about PPD treatment
seeking behaviors. Demographic data were collected from these six mothers during the
interview process (Table 1). Two of the six mothers interviewed felt they did not have an
issue with postpartum depression or anxiety, and therefore did not seek any treatment
resources. One of these mothers said she felt she was “a little emotional” and “just
dealing with typical new mom things,” but did not think she needed any professional
help. Another mother said she had been “feeling down” and was interested in connecting
with resources for PPD, but had not done so five weeks after screening positive for PPD.
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This mother said she experienced many barriers to PPD treatment, including a lack of
time, lack of transportation, and lack of childcare. One-half (3/6) of mothers interviewed
were previously diagnosed with depression before becoming pregnant and were already
receiving mental health services at the time of their PPD screening. These three women
did not identify any specific barriers they experienced in connecting with mental health
resources for PPD.
Discussion
Results of this quality improvement project validate current evidence-based
recommendations for screening mothers for PPD at well-child visits using a standardized
tool such as the EPDS. Just over 9% of mothers (14/152) screened during this process
screened positive for PPD, compared to AAP findings that 11% to 18% of women
experience PPD symptoms after childbirth (Earls et al., 2019). It is not known why this
project had a lower rate of positive screens than estimated by the AAP. One possible
explanation is mothers answering screening questions experienced response bias. One
mother interviewed said “a lot of moms are afraid to speak up.” Another mother said,
“the first time I got screened, I just put the answers they wanted to hear.” Therefore,
mothers as a group may not answer the screening questions honestly.
The process implemented during this project appreciably improved the clinic’s
PPD screening rates. Clinic staff willingly incorporated screening into their intake
process during the project and continued the procedure after the implementation period
was completed. When asked about the 27 mothers (14.8%) who were not screened, staff
members said they simply forgot to give the screening tool to the mothers at check-in,
typically because of busy workloads. In the future, a computerized prompt could be
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incorporated into the check-in process to remind staff to use the screening tool. A second
PDSA cycle is recommended to determine if this change would improve screening rates.
As only eight of the 14 of mothers who screened positive for PPD consented to be
contacted for follow-up, and two of these mothers were unable to be reached by phone,
demographic data and information about barriers accessing PPD treatment resources was
limited by small sample size (n=6). Reasons for mothers declining to be contacted are
unknown. Despite the small sample size, the interview process produced useful
qualitative data that can inform further improvements to the PPD screening and referral
process. It is worthwhile to note five of the six of the mothers interviewed (83%) did not
have a college degree, were not married, had a yearly household income under $50,000,
and had other children in the home. These factors possibly contributed to additional stress
for the mothers, putting them at greater risk for PPD. One of these mothers said she felt
“overwhelmed trying to adjust to a new lifestyle.” while another said she “felt anxious
before the baby, just more intense now.” The mother who had a college degree, was
married, and had a yearly income over $100,000 had no other children at home and did
not agree with screening positive for PPD. She experienced some anxiety making
decisions, but thought her feelings were “typical new mom things.” More data are needed
to better understand how demographic factors influence mothers’ risks for PPD. A
noteworthy finding is that three of the six mothers interviewed were previously diagnosed
with depression, highlighting the need to recognize previous mental health diagnoses as
significant risk factors for PPD.
During phone interviews, mothers were asked to share feelings about the PPD
screening process. All six mothers interviewed felt screening for PPD was valuable but
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had suggestions to improve the process. Three of the six mothers commented on the
importance of personal interaction during the screening process. One mother said, “Some
one-on-one time with an actual person” would be more beneficial than a paper screening.
Another mother said, “It’s easy to check whatever boxes you think you should check. It
would be more helpful if the pediatrician asked questions verbally.” A third mother had
similar feelings, adding, “The vibe and approach that caregivers have is important too.”
She said it is important for mothers to feel they are “Talking with someone who is not
judging them.” All of these comments suggest that although screening mothers using a
written standardized screening tool is valuable, it is important for pediatric providers to
talk with mothers about PPD and express concern about mothers’ feelings during visits.
This project proposes two recommendations for further study. First, it would be
beneficial to study whether or not different rates of positive PPD screens are identified by
completing the PPD screening verbally with a provider instead of on paper. A component
of this study would include mother and provider satisfaction with the process, including
length of time dedicated to data collection and follow-up during provider visits. Another
area for further study is screening for postpartum depression among fathers and other
primary caregivers. During the project implementation period, one father accidentally
filled out the EPDS himself and was found to be at risk for PPD. A recent statement
published by the AAP reports the prevalence of PPD among fathers at 2% to 25% and
recommends pediatric providers assess the mental health of all new parents, including
fathers (Walsh, Davis, & Garfield, 2020). Therefore, future studies and quality
improvement projects should address a screening process for all new parents.
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Conclusion
Screening mothers of infants ages 1-6-months of age for PPD in pediatric primary
care is a beneficial clinical practice. Use of an evidence-based screening tool such as the
EPDS standardizes the screening process, as evidenced by this quality improvement
project. Before implementation of this project, no mothers were screened or identified as
at risk for PPD at the pediatric primary care office. After implementation of this project,
83.5% of mothers were screened for PPD, and 9.2% of those screened were found to be
at risk for PPD. It is important for providers to have an open and honest conversation
with all mothers of infants about PPD and take time to reinforce the need to seek
treatment resources for mothers who screen positive for PPD. This provider follow-up of
the screening process would complement a second PDSA cycle.
This project successfully improved the postpartum depression screening and
referral process in the pediatric clinic. The staff were able to seamlessly incorporate the
screening and referral process into their daily workflow, a protocol they intend to
continue. Findings from this quality improvement project reiterate conclusions from
recent literature that PPD screening using the EPDS is feasible and beneficial in pediatric
primary care (Emerson, Matthews, & Struwe, 2018; Magonia & Schoening, 2017;
Russomagno & Waldrop, 2019). Identifying mothers at risk for PPD through this
screening and referral process can lead to a decrease in negative effects of PPD,
improving long-term child and family physical and mental health.
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Table 1: Demographic characteristics of mothers positive for postpartum depression who
completed screening and follow up calls (n-6).
Mother’s Age >30
Baby’s Age >4 months
Other Children at Home
Work Outside the Home
Married
African American Race
Caucasian Race
College Degree
Yearly Household Income <50,000

3/6
3/6
5/6
2/6
1/6
2/6
4/6
1/6
5/6

SCREENING FOR POSTPARTUM DEPRESSION

20

Figure 1: Edinburgh Postnatal Depression Scale score distribution table
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